$354 Million is the total value of Aequim Alternative Investments LP's 47 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CATM | Exit | CARDTRONICS PLC | $0 | – | -3,800 | -100.0% | -0.05% | – |
Exit | ZILLOW GROUP INCnote 1.500% 7/0 | $0 | – | -3,000,000 | -100.0% | -0.98% | – | |
ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -165,000 | -100.0% | -1.44% | – |
ENRPRA | Exit | ENERGIZER HLDGS INC NEW7.5 mcnv pfd a | $0 | – | -50,000 | -100.0% | -1.74% | – |
Exit | INTEGRATED DEVICE TECHNOLOGYnote 0.875%11/1 | $0 | – | -13,500,000 | -100.0% | -7.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2019-11-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NICE SYS INC | 19 | Q3 2023 | 6.3% |
BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2023 | 0.8% |
EURONET WORLDWIDE ORD | 18 | Q3 2023 | 0.4% |
CLEVELAND CLIFFS ORD | 17 | Q3 2023 | 1.9% |
AIR TRANSPORT SERVICES GRP I | 17 | Q1 2023 | 0.5% |
LIBERTY MEDIA CORP DELAWARE | 16 | Q3 2023 | 5.6% |
ECHOSTAR CORP | 16 | Q3 2023 | 0.9% |
BAUSCH HEALTH COS INC | 15 | Q1 2023 | 0.3% |
O-I GLASS INC | 15 | Q3 2023 | 0.2% |
JAZZ PHARMACEUTICALS PLC | 14 | Q3 2023 | 0.1% |
View Aequim Alternative Investments LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-13 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-15 |
13F-HR | 2023-08-10 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-14 |
SC 13G | 2023-01-10 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
View Aequim Alternative Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.